ProShare Advisors LLC - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$152,092
-9.2%
11,957
+0.5%
0.00%
Q2 2023$167,468
-4.5%
11,894
+4.8%
0.00%
-100.0%
Q1 2023$175,296
-7.0%
11,346
-1.4%
0.00%0.0%
Q4 2022$188,567
-3.8%
11,505
+8.7%
0.00%0.0%
Q3 2022$196,000
+45.2%
10,587
+3.6%
0.00%
Q2 2022$135,000
+8.0%
10,219
-24.4%
0.00%
Q1 2022$125,000
-23.8%
13,515
-19.7%
0.00%
Q4 2021$164,000
-72.3%
16,833
-3.5%
0.00%
-100.0%
Q3 2021$593,000
-21.5%
17,442
-15.4%
0.00%0.0%
Q2 2021$755,000
-7.9%
20,626
+12.8%
0.00%
-33.3%
Q1 2021$820,000
-16.7%
18,285
+6.1%
0.00%
-25.0%
Q4 2020$984,000
+40.4%
17,235
+26.1%
0.00%
+33.3%
Q3 2020$701,000
-16.2%
13,672
-2.4%
0.00%
-25.0%
Q2 2020$837,000
+146.2%
14,009
+69.7%
0.00%
+100.0%
Q1 2020$340,000
-60.1%
8,254
-39.8%
0.00%
-50.0%
Q4 2019$853,000
+62.8%
13,703
-11.2%
0.00%
+33.3%
Q3 2019$524,000
+92.6%
15,432
+27.8%
0.00%
+50.0%
Q2 2019$272,000
-14.7%
12,076
-12.2%
0.00%0.0%
Q1 2019$319,000
+11.1%
13,750
+0.4%
0.00%0.0%
Q4 2018$287,00013,6920.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders